magnifying glass
logo for Alkeus Pharmaceuticals

Alkeus Pharmaceuticals

Get Full Access

Description

Alkeus Pharmaceuticals, Inc. is a private, late-stage biopharmaceutical company developing a novel treatment for Stargardt disease and dry age-related macular d... Read More

Headquarters

Headquarters:

278 Elm St, Ste 229, Somerville, Massachusetts, 02144, United States
Phone

Phone:

(800) 287-2755
Employees

Employees:

28
Revenue

Revenue:

$5 Million
Alkeus Pharmaceuticals's Social Media
SIC Code 28,283
NAICS Code 3254,32541
Popular Searches:

Alkeus Pharmaceuticals Inc

Alkeus Pharmaceuticals , Inc.

Alkeus Pharmaceuticals

Alkeus Pharmaceuticals, Inc.

Alkeus Pharmaceuticals Inc.

Alkeus Pharmaceuticals's Org Chart

Leonide Saad
Leonide Saad

PhD President and Chief Executive O...

PhonePhoneEmailEmail
Nina Johnston
Nina Johnston

Clinical Trial Leader

PhonePhoneEmailEmail
Gabrielle DeBartolomeo
Gabrielle DeBartolomeo

Clinical Trial Scientist

PhonePhoneEmailEmail

PhonePhoneEmailEmail

PhonePhoneEmailEmail
Illustration of an envelope

Alkeus Pharmaceuticals Company Metrics

Company Insights
Employee Growth Rate
Revenue
QuarterRevenue

'20 - Q3

6697000

'20 - Q4

6697000

'21 - Q1

5296000

'21 - Q2

5296000

Alkeus Pharmaceuticals's Tech Stack

Google Analytics

By

Google

Google Font API

By

Google

Sectigo

By

Sectigo

Apache HTTP Server

By

Apache Corporation

jQuery

By

jQuery

AWS Web Hosting

By

Amazon.com
See more technologies

Alkeus Pharmaceuticals News & Media

Alkeus Pharmaceuticals to Present at the 4th Annual Evercore ISI HealthCONx Conference

CAMBRIDGE, MASSACHUSETTS, UNITED STATES, November 29, 2021 /⁨EINPresswire.com⁩/ -- Alkeus Pharmaceuticals, Inc., a late-stage biopharmaceutical company developing a novel treatment for Stargardt disease and geographic atrophy secondary to age-related …

FDA Grants Alkeus Pharmaceuticals Breakthrough Therapy Designation for ALK-001 (C20-D3-vitamin A) for the Treatment of Stargardt Disease

SOMERVILLE, Mass., July 14, 2021 (GLOBE NEWSWIRE) -- Alkeus Pharmaceuticals, Inc., a private, late-stage biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to ALK-001 for the treatment of Stargardt Disease.
Subscribe to "Alkeus Pharmaceuticals" News

Frequently Asked Questions regarding Alkeus Pharmaceuticals

Where are Alkeus Pharmaceuticals’s headquarters?

Alkeus Pharmaceuticals’s headquarters are in 278 Elm St, Ste 229, Somerville, Massachusetts, 02144, United States

What is Alkeus Pharmaceuticals’s phone number?

Alkeus Pharmaceuticals’s phone number is (800) 287-2755

What is Alkeus Pharmaceuticals’s official website?

Alkeus Pharmaceuticals’s official website is //www.alkeuspharma.com

What is Alkeus Pharmaceuticals’s Revenue?

Alkeus Pharmaceuticals’s revenue is $5 Million

What is Alkeus Pharmaceuticals’s SIC code?

Alkeus Pharmaceuticals’s SIC: 28,283

What is Alkeus Pharmaceuticals’s NAICS code?

Alkeus Pharmaceuticals’s NAICS: 3254,32541

How many employees are working in Alkeus Pharmaceuticals?

Alkeus Pharmaceuticals has 28 employees

What is Alkeus Pharmaceuticals’s industry?

Alkeus Pharmaceuticals is in the industry of: Pharmaceuticals, Healthcare, Biotechnology

What is Alkeus Pharmaceuticals's tech stack?

The technologies that are used by Alkeus Pharmaceuticals are: Google Analytics, Google Font API, Sectigo, Apache HTTP Server

Who is Alkeus Pharmaceuticals's CEO?

Alkeus Pharmaceuticals's CEO is Leonide Saad

See more information about Alkeus Pharmaceuticals

Browse ZoomInfo’s Directories